AI Doctor's helper: can a chatbot improve emergency brain care?

NCT ID NCT07626229

Completed Knowledge-focused Sponsor: Capital Medical University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 07, 2026 · Updated 4 times

Summary

This study tests whether an AI tool called Xuanwu-NeuroAid 2.0 can help emergency room doctors better diagnose and treat patients with sudden brain or nerve problems. About 1,360 adults with acute neurological symptoms will be randomly assigned to receive either standard care or care assisted by the AI. The AI provides suggestions, but doctors make all final decisions. The main goal is to see if AI assistance reduces diagnostic errors, unplanned return visits, or harm within 30 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Xuanwu-NeuroAid 2.0 (a large language model AI tool)
What this could lead to: If successful, this could show that AI assistance improves diagnostic accuracy and reduces errors in emergency neurology, potentially leading to better patient outcomes.
What could go wrong: This is an early-stage trial testing a new AI tool. The AI may not improve diagnosis, could introduce errors, or may not be practical in real-world emergency settings. Doctors remain responsible for all decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NERVOUS SYSTEM DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease nervous system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NERVOUS SYSTEM DISEASES

Contacts and locations

Locations

Liuyang Jili Hospital

Guankou, Hunan, 410300, China
Nanyang Nanshi Hospital

Nanyang, Henan, 473000, China
Xuanwu Hospital，Capital Medical University

Beijing, 100053, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.